Special Issue "Fucoidans Ⅱ: Immunomodulating Activity of Fucoidans"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (10 December 2021) | Viewed by 14060
Interests: Seaweeds; fucoidan; environmentally friendly extraction technologies; commercial-grade production; analysis of fucoidans; NMR; medicinal and pharmaceutical chemistry; bioactivities; functionality; functional foods; supplements
Special Issues, Collections and Topics in MDPI journals
Special Issue in Marine Drugs: Marine Natural Products That Target Metabolic Diseases
Special Issue in Marine Drugs: Fucoidans: Structures-Based Bioactivities
Fucoidan is a group of fucose-containing sulfated polysaccharide found in many species of brown seaweed with numerous bioactive properties. As a highly bioactive seaweed substance with many promising physiological activities, fucoidan is attracting attention from many industries all over the world.
Many marine algal polysaccharides such as fucoidans, ulvans, alginic acids, and laminarans exhibit immune-modulating effects which activate and suppress immunity according to circumstances in lives.
This Special Issue is a continuation of a previous Special Issue, “Fucoidans I”, and aims to reveal the immune-modulating effects of fucoidans. Recently, immune-modulating effects have become a particularly attractive topic of interest due to coronavirus infections. The manuscripts published in this Special Issue will help to maintain both human and animal health as well as encourage the development of medicines and functional foods.
As the guest Editor, I would like to invite scientists to submit their latest research findings in this area, in relation to immune-modulating, immune-stimulating, anti-inflammatory and antiviral effects of fucoidans in cells, tissues, organs, and lives.
Prof. Dr. You-Jin Jeon
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- immune-modulating effects
- immune-stimulating effects
- anti-inflammatory effects
- antiviral effects
- cell signaling